Physician profile
Julieann Heathcott
NPI 1689735011
$4,157.31
in general payments reported to CMS, 2019-2025
43 companies · $561 in 2025
The $561 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $263 · 2021: $564 · 2022: $1,072 · 2023: $600 · 2024: $452 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $796.98 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $349.17 | 2021-2025 | |
| Therapeuticsmd, INC. | $343.05 | 2019-2022 | |
| Astellas Pharma US INC | $338.14 | 2019-2025 | Veozah |
| Daiichi Sankyo INC. | $168.76 | 2019-2022 | |
| Hologic Sales and Service, LLC | $147.98 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $147.12 | 2019-2025 | |
| Evofem Biosciences, INC. | $145.57 | 2020-2023 | Phexxi |
| Gynesonics, INC. | $127.38 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $104.16 | 2021-2022 | |
| Millicent US INC | $102.93 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $97.11 | 2022 | |
| Aspira Women'S Health INC | $93.11 | 2022-2024 | Ova1 |
| Exeltis, USA INC. | $84.22 | 2022-2025 | Slynd |
| Merck Sharp & Dohme LLC | $82.34 | 2019-2020 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $78.11 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.10 | 2021-2024 | Xifaxan |
| Lupin INC. | $68.13 | 2019-2021 | |
| Coopersurgical, INC. | $65.12 | 2019-2021 | |
| Channel Medsystems, INC. | $64.67 | 2022 | |
| Scynexis, INC. | $59.27 | 2022 | |
| Biogen, INC. | $54.70 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $52.53 | 2024-2025 | |
| Exact Sciences Corporation | $43.55 | 2023 | Cologuard Collection Kit |
| Minerva Surgical, INC | $40.00 | 2019-2024 | |
| Amgen INC. | $37.67 | 2019 | |
| Novo Nordisk INC | $36.18 | 2023-2024 | Wegovy |
| Alfasigma USA, INC. | $33.05 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $31.70 | 2023 | Myfembree |
| Sage Therapeutics, LLC | $31.10 | 2019-2022 | |
| Dysis Medical, INC. | $27.60 | 2019 | |
| Cook Medical LLC | $25.43 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.72 | 2025 | |
| Becton, Dickinson and Company | $22.62 | 2024 | Bd Onclarity |
| Duchesnay USA Incorporated | $22.06 | 2019 | |
| Agile Therapeutics, INC. | $20.78 | 2021 | |
| Ethicon US, LLC | $20.55 | 2023 | Surgicel Nu-Knit, Megadyne, Stratafix |
| Molnlycke Health Care US, LLC | $18.91 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Meditrina | $18.08 | 2025 | |
| Intra-Sana Laboratories | $14.67 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Medtronic, INC. | $14.60 | 2023 | Truclear |
| Ascend Therapeutics US, LLC | $14.12 | 2023 | |
| Trevena, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julieann Heathcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.